Ignite Creation Date:
2024-07-17 @ 11:02 AM
Last Modification Date:
2024-10-26 @ 3:34 PM
Study NCT ID:
NCT06495138
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-07-11
First Post:
2024-07-02
Brief Title:
Incremental Vestibulo-ocular Reflex Adaptation as a Novel Treatment for Dizziness in People With Multiple Sclerosis
Sponsor:
Emory University
Organization:
Emory University
Study Overview
Official Title:
Daily Versus Intermittent Incremental Vestibulo-ocular Reflex Adaptation as a Novel Treatment for Dizziness in People With Multiple Sclerosis
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
DIIVA-MS
Brief Summary:
The study aims to study the effects of a novel treatment for vestibular symptoms in people with multiple sclerosis The main objective is to determine whether daily personalized gaze stabilization training is more beneficial than intermittent gaze stability training in people with multiple sclerosis
Detailed Description:
People with multiple sclerosis MS often experience dizziness caused by problems in how their brain processes balance signals This dizziness can lead to difficulties keeping their eyes focused on a target while moving their head known as gaze instability This makes activities like walking or driving challenging and dangerous Vestibular physical therapy including gaze stabilization exercises can help The team developed StableEyes a technology that improves gaze stability using a gradual approach to these exercises In the studies StableEyes significantly enhanced gaze stability in people with balance issues Preliminary research in people with MS shows promising results suggesting that tailored gaze stability exercises can further improve their vision stability This method targets the vestibulo-ocular reflex VOR a critical reflex for maintaining clear vision during head movements Improved VOR function can reduce dizziness and improve the quality of life for people with MS
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
True
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
True
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| RG-2307-41945 | OTHER | None | None |